Sheila A. Denton - 15 Jul 2025 Form 4 Insider Report for INCYTE CORP (INCY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Jul 2025, 16:04:54 UTC
Prior SEC filing
07 Jul 2025
Next SEC filing
06 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Elizabeth Feeney, Attorney-In-Fact

Key filing fact

Sheila A. Denton filed Form 4 for INCYTE CORP (INCY) on 17 Jul 2025.

Key facts

  • This page summarizes Sheila A. Denton's Form 4 filing for INCYTE CORP (INCY).
  • 8 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 17 Jul 2025, 16:04.

Change

  • Previous filing in this sequence was filed on 07 Jul 2025.
  • Current net transaction value: -$120,324.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001995298 Primary reporting owner

Denton Sheila A.

Relationship
EVP & General Counsel
Address
1801 AUGUSTINE CUT-OFF, WILMINGTON
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
Signature date
17 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INCY transaction

Common Stock

Options Exercise

Transaction value
$213,952
Shares
+3,330
Change %
+13%
Price
$64.25
Shares after
29,834
Date
15 Jul 2025
Ownership
Direct
INCY transaction

Common Stock

Sale

Transaction value
$232,634
Shares
-3,330
Change %
-11%
Price
$69.86
Shares after
26,504
Date
15 Jul 2025
Ownership
Direct
INCY transaction

Common Stock

Tax liability

Transaction value
$47,980
Shares
-703
Change %
-2.7%
Price
$68.25
Shares after
25,801
Date
15 Jul 2025
Ownership
Direct
Footnotes
F1
INCY transaction

Common Stock

Award

Transaction value
$0
Shares
+8,184
Change %
+32%
Price
$0.000000
Shares after
33,985
Date
15 Jul 2025
Ownership
Direct
Footnotes
F2
INCY transaction

Common Stock

Sale

Transaction value
$53,663
Shares
-785
Change %
-2.3%
Price
$68.36
Shares after
33,200
Date
16 Jul 2025
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INCY transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-3,330
Change %
-25%
Price
$0.000000
Shares after
9,993
Date
15 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,330
Exercise price
$64.25
Footnotes
F4
INCY transaction Derivative

Performance Shares

Award

Transaction value
$0
Shares
+20,461
Change %
Price
$0.000000
Shares after
20,461
Date
15 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,461
Exercise price
Footnotes
F5
INCY transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+18,419
Change %
Price
$0.000000
Shares after
18,419
Date
15 Jul 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
18,419
Exercise price
$68.25
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock.

Footnote F2

Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.

Footnote F3

Including the July 15, 2025 grant, this includes an aggregate of 32,544 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested.

Footnote F4

The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Footnote F5

Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

Footnote F6

The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .